AGIOS PHARMACEUTICALS, INC. - COM (AGIO)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
58.2 M
Holdings value Q1 2024
$1.7 B
Value change Q1 2024
+$59.5 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
176
Number of buys Q1 2024
96
Number of sells Q1 2024
-78
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
0%
CUSIP
00847X104
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 58.2 M $1.7 B +$59.5 M $29.24 179
2023 Q4 57.2 M $1.27 B -$15.5 M $22.27 164
2023 Q3 57.1 M $1.41 B -$4.96 M $24.75 141
2023 Q2 57.1 M $1.62 B +$12.2 M $28.32 147
2023 Q1 57.1 M $1.31 B -$9.97 M $22.97 158
2022 Q4 57.6 M $1.62 B +$41.4 M $28.08 154
2022 Q3 52.5 M $1.48 B -$7.97 M $28.28 149
2022 Q2 56.5 M $1.25 B -$31.6 M $22.17 134
2022 Q1 57.8 M $1.68 B +$21.4 M $29.11 137
2021 Q4 57.2 M $1.88 B -$91.3 M $32.87 144
2021 Q3 59.7 M $2.75 B -$247 M $46.15 155
2021 Q2 64.8 M $3.57 B +$49.5 M $55.11 178
2021 Q1 64.2 M $3.31 B +$57.9 M $51.64 169
2020 Q4 63.8 M $2.76 B -$17.9 M $43.33 183
2020 Q3 64.4 M $2.25 B -$115 M $35.00 199
2020 Q2 66.4 M $3.55 B -$65.4 M $53.48 198
2020 Q1 68 M $2.41 B +$8.75 M $35.48 179
2019 Q4 67.6 M $3.23 B +$337 M $47.75 187
2019 Q3 61 M $1.98 B +$38.7 M $32.40 170
2019 Q2 59.9 M $2.99 B +$322 M $49.88 179
2019 Q1 59.5 M $4.02 B +$162 M $67.44 187
2018 Q4 57.4 M $2.65 B +$50 M $46.11 179
2018 Q3 55.7 M $4.29 B +$92.8 M $77.12 199
2018 Q2 54.4 M $4.58 B -$2.8 M $84.23 206
2018 Q1 54.9 M $4.48 B +$717 M $81.78 193
2017 Q4 47 M $2.69 B +$50.5 M $57.17 174
2017 Q3 46.1 M $3.07 B +$18 M $66.75 170
2017 Q2 46.2 M $2.37 B +$269 M $51.45 167
2017 Q1 41 M $2.39 B +$241 M $58.40 156
2016 Q4 38.9 M $1.62 B +$47.9 M $41.73 153
2016 Q3 37.8 M $1.99 B +$251 M $52.82 160
2016 Q2 34 M $1.42 B +$19.6 M $41.89 150
2016 Q1 33.8 M $1.37 B +$17.8 M $40.60 147
2015 Q4 33 M $2.14 B +$93.2 M $64.92 136
2015 Q3 31.4 M $2.22 B +$86.5 M $70.59 149
2015 Q2 30 M $3.33 B +$252 M $111.14 159
2015 Q1 27.9 M $2.64 B -$37 M $94.30 149
2014 Q4 27.6 M $3.1 B +$395 M $112.04 144
2014 Q3 24.5 M $1.5 B +$80.4 M $61.35 118
2014 Q2 23.6 M $1.08 B +$141 M $45.82 98
2014 Q1 20.5 M $804 M +$94 M $39.15 73